Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 17028
Country/Region: South Africa
Year: 2016
Main Partner: University of the Witwatersrand
Main Partner Program: Wits Reproductive Health and HIV Institute
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $0 Additional Pipeline Funding: $2,153,253

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Age/sex: 10-14 Female 2017 182
HTS_TST Age/sex: 10-14 Female 2017 28
HTS_TST Age/sex: 10-14 Male 2017 78
HTS_TST Age/sex: 10-14 Male 2017 12
HTS_TST Age/sex: 15-19 Female 2017 2,964
HTS_TST Age/sex: 15-19 Female 2017 456
HTS_TST Age/sex: 15-19 Male 2017 598
HTS_TST Age/sex: 15-19 Male 2017 92
HTS_TST Age/sex: 20-24 Female 2017 5,759
HTS_TST Age/sex: 20-24 Female 2017 886
HTS_TST Age/sex: 20-24 Male 2017 1,144
HTS_TST Age/sex: 20-24 Male 2017 176
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 811
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 28
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 384
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 12
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 18,736
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 1,342
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 4,819
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 268
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 24,750
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 1,650
HTS_TST Service Delivery Point (Facility): VCT 2017 24,750
HTS_TST Service Delivery Point (Facility): VCT 2017 1,650
HTS_TST Sum of Age/Sex disaggregates 2017 10,725
HTS_TST Sum of Age/Sex disaggregates 2017 1,650
HTS_TST Sum of Aggregated Age/Sex <15 2017 1,195
HTS_TST Sum of Aggregated Age/Sex <15 2017 40
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 23,555
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 1,610
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 24,750
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 1,650
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 13
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 2
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 65
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 10
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 234
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 36
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 52
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 8
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 468
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 72
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 91
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 14
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 64
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 2
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 150
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 10
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,501
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 108
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 381
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 22
PP_PREV Aggregated Age/sex: 15+ Female 2017 13,476
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 13,476
PP_PREV Total number of people in the target population 2017 216,607
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1,738
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 168
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 6,056
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 338
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1,503
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 158
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 4,083
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 228
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 14,850
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 990
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 13,380
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 892
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 148
TB_SCREENDX [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 2,072
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 148
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Other (Not Xpert) 2017 2,072
TB_SCREENDX Screen Result: Screened Positive for TB 2017 148
TB_SCREENDX Screen Results: Screened Positive for TB 2017 2,072
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 1,523
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 1,557
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 9,600
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 674
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 2,170
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 156
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 80
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 80
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 14,850
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 990
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 3,063
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 296
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 10,661
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 594
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 2,644
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 276
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 7,152
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 402
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 23,520
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 1,568
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 24,750
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 1,650
TX_CURR Age/Sex: 10-14 Female 2017 351
TX_CURR Age/Sex: 10-14 Female 2017 54
TX_CURR Age/Sex: 10-14 Male 2017 377
TX_CURR Age/Sex: 10-14 Male 2017 58
TX_CURR Age/Sex: 15-19 Female 2017 624
TX_CURR Age/Sex: 15-19 Female 2017 96
TX_CURR Age/Sex: 15-19 Male 2017 208
TX_CURR Age/Sex: 15-19 Male 2017 32
TX_CURR Age/Sex: 20-24 Female 2017 1,196
TX_CURR Age/Sex: 20-24 Female 2017 184
TX_CURR Age/Sex: 20-24 Male 2017 416
TX_CURR Age/Sex: 20-24 Male 2017 64
TX_CURR Aggregated Age/Sex: <15 Female 2017 827
TX_CURR Aggregated Age/Sex: <15 Female 2017 54
TX_CURR Aggregated Age/Sex: <15 Male 2017 887
TX_CURR Aggregated Age/Sex: <15 Male 2017 58
TX_CURR Aggregated Age/Sex: 15+ Female 2017 4,455
TX_CURR Aggregated Age/Sex: 15+ Female 2017 280
TX_CURR Aggregated Age/Sex: 15+ Male 2017 1,151
TX_CURR Aggregated Age/Sex: 15+ Male 2017 96
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 7,320
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 488
TX_CURR Sum of age/sex disaggregates 2017 128
TX_CURR Sum of Age/Sex disaggregations 2017 832
TX_CURR Sum of Aggregated Age/Sex <15 2017 1,714
TX_CURR Sum of Aggregated Age/Sex <15 2017 112
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 5,606
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 376
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 7,320
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 488
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 30
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 2
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 32
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 2,496
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 160
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 262
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 26
TX_NEW By Age/Sex: 10-14 Female 2017 13
TX_NEW By Age/Sex: 10-14 Female 2017 2
TX_NEW By Age/Sex: 15-19 Female 2017 351
TX_NEW By Age/Sex: 15-19 Female 2017 54
TX_NEW By Age/Sex: 15-19 Male 2017 52
TX_NEW By Age/Sex: 15-19 Male 2017 8
TX_NEW By Age/Sex: 20-24 Female 2017 689
TX_NEW By Age/Sex: 20-24 Female 2017 106
TX_NEW By Age/Sex: 20-24 Male 2017 117
TX_NEW By Age/Sex: 20-24 Male 2017 18
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 2,820
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 188
TX_NEW Sum of Age/Sex disaggregates 2017 1,222
TX_NEW Sum of Age/Sex disaggregates 2017 188
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 2,820
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 188
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 6,600
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 440
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 5,940
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 396
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 400
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 4
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 286
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 10
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 4,507
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 322
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 747
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 60
TX_PVLS Numerator: Indication: Routine 2017 5,940
TX_PVLS Numerator: Indication: Routine 2017 396
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 451
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 50
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 316
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 52
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 4,913
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 252
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 920
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 86
TX_PVLS_den Denominator: Indication: Routine 2017 6,600
TX_PVLS_den Denominator: Indication: Routine 2017 440
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 325
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 50
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 338
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 52
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 559
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 86
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 195
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 30
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,079
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 166
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 364
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 56
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 775
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 50
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 842
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 52
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 4,140
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 252
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,063
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 86
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 6,820
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 440
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 7,320
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 488
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 351
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 54
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 377
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 58
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 611
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 94
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 221
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 34
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,196
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 184
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 416
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 64
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 827
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 54
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 874
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 56
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 4,468
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 282
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,151
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 96